Management of patients with cardiac stents undergoing noncardiac surgery

Current Opinion in Anaesthesiology

Volumn 20, Issue 3, 2007, Pages 274-278

  Schouten, Olaf ^a   Bax, Jeroen J ^b   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antiplatelet therapy; Bleeding; Coronary stents; Noncardiac surgery; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; RAPAMYCIN;

ADVERSE OUTCOME; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY STENT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; NON INVASIVE PROCEDURE; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOSIS; VEIN THROMBOSIS;

ANESTHESIA; HUMANS; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; STENTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 34247860819     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328105dac5     Document Type: Review

References (30)

1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
2. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355:1093-1104.
3. Shuchman M. Trading restenosis for thrombosis? New questions about drug-eluting stents. N Engl J Med 2006; 355:1949-1952. An interesting leading article on the possible benefits and risks of drug-eluting stents vs. bare metal stents, particularly late in-stent thrombosis.
4. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45:954-959.
5. Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and noncardiac surgery - a prospective outcome study. Br J Anaesth 2006; 96:686-693. An excellent prospective study of 103 patients indicating that patients with coronary stents are at increased risk for perioperative stent-related complications, particularly if surgery is performed early after stenting.
6. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47:216-235. Guidelines for coronary stenting; indications and duration of (dual) antiplatelet therapy.
7. KaluzaGL, Joseph J, Lee JR, et al. Catastrophic outcomesof noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288-1294.
8. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004; 63:141-145.
9. Leibowitz D, Cohen M, Planer D, et al. Comparison of cardiovascular risk of noncardiac surgery following coronary angioplasty with versus without stenting. Am J Cardiol 2006; 97:1188-1191.
10. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing noncardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42:234-240.
11. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 2005; 95:755-757.
12. Schouten O, Bax JJ, Damen J, Poldermans D. Coronary artery stent placement immediately prior to non-cardiac surgery; a potential risk? Anesthesiology 2007, in press.
13. Schouten O, Van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49:122-124. Recent study, including both bare metal stents and drug-eluting stents (192 patients). Early surgery and antiplatelet discontinuation were associated with an increased risk of perioperative cardiac events.
14. Compton PA, Zankar AA, Adesanya AO, et al. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006; 98:1212-2123. Study showing a relatively low incidence of perioperative cardiac events in patients with drug-eluting stents.
15. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113:2803-2809.
16. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
17. Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288:2411-2420.
18. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297:159-168.
19. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48:2584-2591.
20. Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 2004; 43:963-981.
21. Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257:399-414.
22. Horlocker TT, Wedel DJ, Offord KP. Does preoperative antiplatelet therapy increase the risk of hemorrhagic complications associated with regional anesthesia? Anesth Analg 1990; 70:631-634.
23. Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg 1995; 80:303-309.
24. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28:172-197.
25. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery - Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002; 94:1052-1064.
26. Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation 1997; 96:1882-1887.
27. Hassan SA, Hlatky MA, Boothroyd DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001; 110:260-266.
28. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
29. Poldermans D, Schouten O, Vidakovic R, et al. The effect of preventive coronary revascularization on postoperative outcome in patients undergoing major vascular surgery with extensive stress-induced myocardial ischemia during preoperative testing. Circulation 2006; 144:II-523. A randomized trial in very high cardiac risk patients to assess the effect of preoperative prophylactic coronary revascularization. No benefit was found.
30. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.